Wells Fargo & Company Harmony Biosciences Holdings, Inc. Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025

A detailed history of Wells Fargo & Company transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 110,116 shares of HRMY stock, worth $3.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,116
Previous 103,780 6.11%
Holding current value
$3.91 Million
Previous $3.44 Million 1.02%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$27.94 - $35.91 $177,027 - $227,525
6,336 Added 6.11%
110,116 $3.48 Million
Q1 2025

May 13, 2025
BUY
$32.18 - $40.46 $2.76 Million - $3.47 Million
85,775 Added 476.4%
103,780 $3.44 Million
Q4 2024

Feb 12, 2025
SELL
$31.86 - $41.49 $3.04 Million - $3.96 Million
-95,490 Reduced 84.14%
18,005 $619,000
Q3 2024

Nov 13, 2024
BUY
$30.0 - $39.95 $2.9 Million - $3.86 Million
96,727 Added 576.85%
113,495 $4.53 Million
Q2 2024

Aug 13, 2024
BUY
$28.81 - $33.01 $662 - $759
23 Added 0.14%
16,768 $505,000
Q1 2024

May 10, 2024
BUY
$29.93 - $35.06 $37,921 - $44,421
1,267 Added 8.19%
16,745 $562,000
Q4 2023

Feb 09, 2024
BUY
$19.2 - $33.78 $10,425 - $18,342
543 Added 3.64%
15,478 $499,000
Q3 2023

Nov 13, 2023
SELL
$31.89 - $39.03 $860,998 - $1.05 Million
-26,999 Reduced 64.38%
14,935 $489,000
Q2 2023

Aug 15, 2023
BUY
$30.5 - $37.4 $221,491 - $271,598
7,262 Added 20.94%
41,934 $1.48 Million
Q1 2023

May 12, 2023
BUY
$30.8 - $53.92 $302,794 - $530,087
9,831 Added 39.58%
34,672 $1.13 Million
Q4 2022

Feb 13, 2023
BUY
$45.4 - $60.91 $655,848 - $879,905
14,446 Added 138.97%
24,841 $1.37 Million
Q3 2022

Nov 14, 2022
SELL
$42.06 - $55.45 $181,152 - $238,823
-4,307 Reduced 29.3%
10,395 $460,000
Q2 2022

Aug 12, 2022
SELL
$33.54 - $52.15 $76,773 - $119,371
-2,289 Reduced 13.47%
14,702 $717,000
Q1 2022

May 16, 2022
SELL
$33.14 - $51.13 $247,820 - $382,350
-7,478 Reduced 30.56%
16,991 $827,000
Q4 2021

Feb 14, 2022
SELL
$34.09 - $43.91 $1.97 Million - $2.53 Million
-57,675 Reduced 70.21%
24,469 $1.04 Million
Q3 2021

Nov 15, 2021
BUY
$25.68 - $38.61 $1.86 Million - $2.79 Million
72,383 Added 741.55%
82,144 $3.15 Million
Q2 2021

Aug 16, 2021
BUY
$25.96 - $33.44 $74,167 - $95,538
2,857 Added 41.38%
9,761 $276,000
Q1 2021

May 13, 2021
SELL
$27.56 - $40.37 $725,158 - $1.06 Million
-26,312 Reduced 79.21%
6,904 $228,000
Q4 2020

Feb 09, 2021
BUY
$31.74 - $51.34 $1.02 Million - $1.65 Million
32,216 Added 3221.6%
33,216 $1.2 Million
Q3 2020

Nov 05, 2020
BUY
$30.96 - $44.39 $30,960 - $44,390
1,000 New
1,000 $34,000

Others Institutions Holding HRMY

# of Institutions
288
Shares Held
46.2M
Call Options Held
316K
Put Options Held
69.9K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.1B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email